Literature DB >> 20089377

PET and PET/CT in endocrine tumours.

Robert Dudczak1, Tatjana Traub-Weidinger.   

Abstract

Functional information provided by PET tracers together with the superior image quality and the better data quantification by PET technology had a changing effect on the significance of nuclear medicine in medical issues. Recently introduced hybrid PET/CT systems together with the introduction of novel PET radiopharmaceuticals have contributed to the fact that nuclear medicine has become a growing diagnostic impact on endocrinology. In this review imaging strategies, different radiopharmaceuticals including the basic mechanism of their cell uptake, and the diagnostic value of PET and PET/CT in endocrine tumours except differentiated thyroid carcinomas will be discussed. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20089377     DOI： 10.1016/j.ejrad.2009.12.024

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN： 0720-048X            Impact factor:   3.528


  5 in total

1.  Comparison of 6-18F-fluoro-L-DOPA, 18F-2-deoxy-D-glucose, CT, and MRI in patients with pancreatic neuroendocrine neoplasms with von Hippel-Lindau disease.

Authors:  Mio Kitano; Corina Millo; Reza Rahbari; Peter Herscovitch; Krisana Gesuwan; Richard C Webb; Aradhana M Venkatesan; Giao Q Phan; Marybeth S Hughes; Steven K Libutti; Naris Nilubol; William M Linehan; Electron Kebebew
Journal:  Surgery       Date:  2011-12       Impact factor: 3.982

Review 2.  Place of surgical resection in the treatment strategy of gastrointestinal neuroendocrine tumors.

Authors:  Sébastien Gaujoux; Alain Sauvanet; Jacques Belghiti
Journal:  Target Oncol       Date:  2012-08-25       Impact factor: 4.493

3.  ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes.

Authors:  Robert T Jensen; Guillaume Cadiot; Maria L Brandi; Wouter W de Herder; Gregory Kaltsas; Paul Komminoth; Jean-Yves Scoazec; Ramon Salazar; Alain Sauvanet; Reza Kianmanesh
Journal:  Neuroendocrinology       Date:  2012-02-15       Impact factor: 4.914

4.  Evolving management of insulinoma: Experience at a tertiary care centre.

Authors:  Viveka P Jyotsna; Sujoy Pal; D Kandasamy; S Gamanagatti; P K Garg; N Raizada; Peush Sahni; C S Bal; N Tandon; A C Ammini
Journal:  Indian J Med Res       Date:  2016-11       Impact factor: 2.375

5.  Extrathyroidal Calcitonin Secreting Tumors: Pancreatic Neuroendocrine Tumors in Patients With Multinodular Goiter: Two Case Reports.

Authors:  Elisa Giannetta; Daniele Gianfrilli; Carlotta Pozza; Rosa Lauretta; Chiara Graziadio; Emilia Sbardella; Alberto Baroli; Roberto Caronna; Piero Chirletti; Andrea Lenzi; Andrea M Isidori
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.